HBP.TO
Price:
$2.1
Market Cap:
$160.39M
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered ...[Read more]
Industry
Biotechnology
IPO Date
1996-08-13
Stock Exchange
TSX
Ticker
HBP.TO
According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 160.66M. This represents a change of 520.67% compared to the average of 25.89M of the last 4 quarters.
The mean historical Enterprise Value of Helix BioPharma Corp. over the last ten years is 72.22M. The current 160.66M Enterprise Value has changed 22.15% with respect to the historical average. Over the past ten years (40 quarters), HBP.TO's Enterprise Value was at its highest in in the April 2020 quarter at 204.03M. The Enterprise Value was at its lowest in in the January 2025 quarter at 7.22M.
Average
72.22M
Median
62.40M
Minimum
27.62M
Maximum
154.62M
Discovering the peaks and valleys of Helix BioPharma Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 76.45%
Maximum Annual Enterprise Value = 154.62M
Minimum Annual Increase = -75.88%
Minimum Annual Enterprise Value = 27.62M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 59.91M | 19.63% |
| 2024 | 50.08M | 25.92% |
| 2023 | 39.77M | 44.00% |
| 2022 | 27.62M | -75.88% |
| 2021 | 114.49M | 76.45% |
| 2020 | 64.89M | 9.03% |
| 2019 | 59.52M | -14.47% |
| 2018 | 69.58M | -14.85% |
| 2017 | 81.72M | -47.15% |
| 2016 | 154.62M | 2.27% |
The current Enterprise Value of Helix BioPharma Corp. (HBP.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
49.92M
5-year avg
58.37M
10-year avg
72.22M
Helix BioPharma Corp.’s Enterprise Value is less than Jushi Holdings Inc. (399.81M), greater than Satellos Bioscience Inc. (41.10M), greater than Cybin Inc. (145.60M), less than Cannara Biotech Inc. (196.59M), greater than HLS Therapeutics Inc. (150.27M), greater than Medicenna Therapeutics Corp. (55.99M), greater than Cardiol Therapeutics Inc. (109.97M), less than Quipt Home Medical Corp. (194.62M), greater than Sernova Corp. (47.11M), greater than Resverlogix Corp. (29.39M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 399.81M | $212.43M | |
| 41.10M | $124.02M | |
| 145.60M | $219.79M | |
| 196.59M | $163.53M | |
| 150.27M | $156.66M | |
| 55.99M | $76.29M | |
| 109.97M | $128.02M | |
| 194.62M | $156.40M | |
| 47.11M | $44.37M | |
| 29.39M | $31.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Helix BioPharma Corp.'s Enterprise Value?
What is the highest Enterprise Value for Helix BioPharma Corp. (HBP.TO)?
What is the 3-year average Enterprise Value for Helix BioPharma Corp. (HBP.TO)?
What is the 5-year average Enterprise Value for Helix BioPharma Corp. (HBP.TO)?
How does the current Enterprise Value for Helix BioPharma Corp. (HBP.TO) compare to its historical average?